Learn More
BACKGROUND Pharmacokinetic (PK) interactions between lopinavir/ritonavir (LPV/r) and transdermally delivered ethinyl estradiol (EE) and norelgestromin (NGMN) are unknown. METHODS Using a standard(More)
CONTEXT Approaches to preserve or enhance immune function in HIV-1 infection are needed. OBJECTIVES To examine the ability of daily low-dose interleukin-2 (IL-2) in combination with antiretroviral(More)